Lab Session: AI and Pharma in the Near Term
Artificial intelligence (AI) is everywhere, promising self driving cars, medical breakthroughs, and entirely new ways of working. But how do we separate the hype from reality?
In 2016, we convened executives for a Lab Session to better understand how to apply AI to solve real business problems. Hilary Mason, founder and CEO of Fast Forward Labs, and Sandy Allerheiligen, VP of Data Science and Predictive and Economic Modeling at Merck, discussed what leaders need to know in the near-term.
MM&M also featured insights from the event in their piece “Pharma adopts data-science culture in move toward AI”, exploring why data scientists are flocking to Pharma.